Showing results (71-80 of 217) with videos related to

Sort By:
Pageof 22
Rheumatology (Oxford, England)|December 19, 2022
Determinants of health-related quality of life across the spectrum of connective tissue diseases using latent profile analysis: results from the LEAP cohortSarah Dyball, John A Reynolds, Ariane L Herrick, et al.
Arthritis Research & Therapy|August 12, 2021
Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the PRe-clinical EValuation of Novel Targets in RA (PREVeNT-RA) CohortR E Costello, J H Humphreys, J C Sergeant, et al.
Rheumatology (Oxford, England)|August 26, 2022
Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: a post hoc analysis of the TULIP-1 and TULIP-2 trialsIan N Bruce, Ronald F van Vollenhoven, Eric F Morand, et al.
Clinical Immunology (Orlando, Fla.)|February 5, 2022
Longitudinal analysis of urinary proteins in lupus nephritis - A pilot studyEmil Carlsson, Alexandra Quist, Jennifer C Davies, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 30, 2008
The apolipoprotein E2 isoform is associated with accelerated onset of coronary artery disease in systemic lupus erythematosusAntonio Orlacchio, Ian N Bruce, Proton Rahman, et al.
Lupus Science & Medicine|January 25, 2022
Immune gene expression and functional networks in distinct lupus nephritis classesAlyssa C Gilmore, Hannah R Wilson, Thomas D Cairns, et al.
Arthritis and Rheumatism|February 13, 2013
Shortened telomere length in patients with systemic lupus erythematosusSahena Haque, Chadi Rakieh, Fiona Marriage, et al.
The Lancet. Rheumatology|January 27, 2024
Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase 2 studyIan N Bruce, Alireza Nami, Erik Schwetje, et al.
The Journal of Rheumatology|January 6, 2006
Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosusMasoud El Magadmi, Yasmeen Ahmad, Wajdi Turkie, et al.
Orphanet Journal of Rare Diseases|June 16, 2026
Refining Human Phenotype Ontology (HPO) to enable better phenotype-genotype integration in systemic autoimmune rheumatic diseasesAnastasia-Vasiliki Madenidou, Gillian I Rice, Sarah Dyball, et al.
Pageof 22